header logo

Terms of Use

The information contained on this site is for healthcare professionals only.

I am a healthcare professional from
Choose a Country ▼


Amgen is excited to participate in
ESC Congress 2020 – The Digital Experience

ESC Congress 2020 is set to be the largest online gathering of cardiovascular professionals the world has ever seen, featuring 4000 abstract presentations, new ESC Guidelines, and a full abstract programme – all exclusively online and free of charge!
This year, Amgen is hosting two symposia which will be available live on the ESC Prime Time Channel and on-demand for the next 12 months. Save the date for these unmissable sessions:
  • PCSK9 inhibitors from bench to real world: A journey to improve CV outcomes in very-high-risk patients
    (Chair: Christie Ballantyne, US) – Tuesday 1st September: 15:00–15:30 Central European Summer Time (CEST)
  • LDL-C management in ACS patients: Lower is better but is earlier better?
    (Chairs: Gilles Montalescot, France, and Marc Sabatine, US) – Tuesday 1st September: 17:30–18:15 CEST

To register and find out more, visit the official ESC Congress 2020 website here.

*In the study, 2690 recent MI patients received Repatha®, 2254 of whom achieved LDL-C levels <55 mg/dl.
25% RRR reported as the key secondary endpoint: composite of cardiovascular death, MI or stroke. HR: 0.75; 95% CI: 0.62-0.91; p=0.003. ARR: 3.2%; 95% CI: 1.2-5.2.
ACS = Acute coronary syndrome; AHA = American Heart Association; ARR = Absolute risk reduction; CV = Cardiovascular; EAS = European Atherosclerosis Society; ESC = European Society of Cardiology; EVOPACS = EVOlocumab for Early Reduction of LDL-cholesterol Levels in Patients With Acute Coronary Syndromes; FOURIER = Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk; LDL-C = Low-density lipoprotein cholesterol; MI = Myocardial infarction; PCSK9 = Protein convertase subtilisin/kexin type 9; RRR = Relative risk reduction.
  1. Gencer B, et al. JAMA Cardiol. 2020; Online first. doi:10.1001/jamacardio.2020.0882.

By clicking the 'DOWNLOAD' button below you will immediately begin downloading the Reporting Systems Appendix
Return to previous page DOWNLOAD